Yuki Y - Search Results

1

Human Norovirus Propagation in Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Cells.

Sato S, Hisaie K, Kurokawa S, Suzuki A, Sakon N, Uchida Y, Yuki Y, Kiyono H. Sato S, et al. Among authors: yuki y. Cell Mol Gastroenterol Hepatol. 2019;7(3):686-688.e5. doi: 10.1016/j.jcmgh.2018.11.001. Epub 2018 Dec 10. Cell Mol Gastroenterol Hepatol. 2019. PMID: 30543870 Free PMC article. No abstract available.

2

Human milk proteins including secretory IgA fail to elicit tolerance after feeding.

Yuki Y, Fujihashi K, Yamamoto M, McGhee JR, Kiyono H. Yuki Y, et al. Int Immunol. 1998 Apr;10(4):537-45. doi: 10.1093/intimm/10.4.537. Int Immunol. 1998. PMID: 9620610

3

Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).

Yura M, Takahashi I, Serada M, Koshio T, Nakagami K, Yuki Y, Kiyono H. Yura M, et al. Among authors: yuki y. J Autoimmun. 2001 Aug;17(1):17-25. doi: 10.1006/jaut.2001.0520. J Autoimmun. 2001. PMID: 11488634

4

Nasal administration of cholera toxin (CT) suppresses clinical signs of experimental autoimmune encephalomyelitis (EAE).

Yura M, Takahashi I, Terawaki S, Hiroi T, Kweon MN, Yuki Y, Kiyono H. Yura M, et al. Among authors: yuki y. Vaccine. 2001 Oct 12;20(1-2):134-9. doi: 10.1016/s0264-410x(01)00278-x. Vaccine. 2001. PMID: 11567757

5

Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit.

Boyaka PN, Ohmura M, Fujihashi K, Koga T, Yamamoto M, Kweon MN, Takeda Y, Jackson RJ, Kiyono H, Yuki Y, McGhee JR. Boyaka PN, et al. Among authors: yuki y. J Immunol. 2003 Jan 1;170(1):454-62. doi: 10.4049/jimmunol.170.1.454. J Immunol. 2003. PMID: 12496431

6

[M cells: development and function].

Yuki Y, Kiyono H. Yuki Y, et al. Tanpakushitsu Kakusan Koso. 2002 Dec;47(16 Suppl):2325-30. Tanpakushitsu Kakusan Koso. 2002. PMID: 12518456 Review. Japanese. No abstract available.

7

New generation of mucosal adjuvants for the induction of protective immunity.

Yuki Y, Kiyono H. Yuki Y, et al. Rev Med Virol. 2003 Sep-Oct;13(5):293-310. doi: 10.1002/rmv.398. Rev Med Virol. 2003. PMID: 12931340 Review.

8

Intestinal villous M cells: an antigen entry site in the mucosal epithelium.

Jang MH, Kweon MN, Iwatani K, Yamamoto M, Terahara K, Sasakawa C, Suzuki T, Nochi T, Yokota Y, Rennert PD, Hiroi T, Tamagawa H, Iijima H, Kunisawa J, Yuki Y, Kiyono H. Jang MH, et al. Among authors: yuki y. Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6110-5. doi: 10.1073/pnas.0400969101. Epub 2004 Apr 7. Proc Natl Acad Sci U S A. 2004. PMID: 15071180 Free PMC article.

9

Non-toxic Stx derivatives from Escherichia coli possess adjuvant activity for mucosal immunity.

Ohmura-Hoshino M, Yamamoto M, Yuki Y, Takeda Y, Kiyono H. Ohmura-Hoshino M, et al. Among authors: yuki y. Vaccine. 2004 Sep 9;22(27-28):3751-61. doi: 10.1016/j.vaccine.2004.03.034. Vaccine. 2004. PMID: 15315856

10

Biological role of Ep-CAM in the physical interaction between epithelial cells and lymphocytes in intestinal epithelium.

Nochi T, Yuki Y, Terahara K, Hino A, Kunisawa J, Kweon MN, Yamaguchi T, Kiyono H. Nochi T, et al. Among authors: yuki y. Clin Immunol. 2004 Dec;113(3):326-39. doi: 10.1016/j.clim.2004.08.013. Clin Immunol. 2004. PMID: 15507398

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

202 results

Search Page